Stockreport

Fourth quarter and full year 2022 financial results and business update

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Evaxion presented promising data from its Phase 1/2a clinical trial of EVX-02 in patients with late-stage melanoma at the 2023 AACR meetingEVX-03, a DNA-based personaliz [Read more]